buPROPion Hydrochloride Extended-Release Tablets recall
buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East…
Why was buPROPion Hydrochloride Extended-Release Tablets recalled?
Presence of Foreign Tablets/Capsules
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: BPA123098A, Exp. Date 06/2025
- Product
- buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East…
- Recalling firm
- Rising Pharma Holding, Inc.
- Quantity
- 47,976 bottles
- Distribution
- Nationwide within the United States
- Recall date
- January 17, 2024
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)